Results 141 to 150 of about 141,694 (266)

Antibiotic‐mediated immune modulation in periodontitis

Periodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez, R. M. Arce, Camila Pinheiro Furquim, Cristiane Gonçalves, Alpdogan Kantarci, Magda Feres, Nidia C. Castro dos Santos   +6 more
wiley   +1 more source

Efficacy and predictors of pegylated-interferon in hepatitis B surface antigen seroclearance in immune active and inactive chronic hepatitis B patients. [PDF]

J Virus Erad
Han C, Jin L, Zhu M, Qin Q, Li G, Liu Z, Zhang X.   +6 more
europepmc   +1 more source

Subtypes of Hepatitis B Surface Antigen in Turkey

Japanese Journal of Infectious Diseases, 2005
Yalcinkaya, Kezban Tulay, Ucar, Hasan, Uzun, Mustafa, Esen, Berrin, Shirachi, Ryoichi, Miyamura, Kikuko, Yamamoto, Hiroshi   +6 more
openaire   +2 more sources

Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization

Transplant Infectious Disease, EarlyView.
Rare instances occur in which discriminatory NAT results cannot be resolved in deceased organ donor cases. When these events occur the impact on organ donation can be substantial. ABSTRACT Background Nucleic acid testing (NAT) is essential for detecting transmissible viral infections in deceased organ donors and guiding safe organ allocation.
Sara Dionne, Hillary Akana, Kaitlin Logue, Brenden O'Neale, Chris Curran, Sean VanSlyck   +5 more
wiley   +1 more source

Quantitative Change of Hepatitis B Surface Antigen Leading to Final Hepatitis B Surface Antigen Loss in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in China. [PDF]

Clin Transl Gastroenterol
Zhou T, Shu M, Luo F, Dong S, Teng J, Du Y, Qiu H, Cai W.   +7 more
europepmc   +1 more source

Transfection of unmodified oligodeoxynucleotide with polyethylenimine reduces the level of hepatitis B surface antigen. [PDF]

Front Microbiol
Lin J, Li J.
europepmc   +1 more source

Impaired hematopoiesis affects apheresis and CAR T‐cell product composition and treatment response

Transfusion, EarlyView.
Abstract Background Chimeric antigen receptor (CAR) T‐cell therapy has transformed the treatment of hematologic malignancies, but its success depends on obtaining sufficient CD3+ T‐cell yields during leukapheresis. This can be difficult in heavily pretreated patients, who often show leukopenia and reduced T‐cell fitness.
Hanna Kuhn, Felix Korell, Angela Hückelhoven‐Krauss, Brigitte Neuber, Miriam Stenzinger, Anita Ludwig‐Husemann, Maria‐Luisa Schubert, Patrick Derigs, Kiavasch Farid, Tim Sauer, Sandra Sauer, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt, Anita Schmitt   +14 more
wiley   +1 more source

Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B. [PDF]

World J Gastrointest Surg
Li J, Li M, Sun H, Yu YT, Zhou YH, Fu F, Yan L.   +6 more
europepmc   +1 more source

Residual risk of human immunodeficiency virus, hepatitis C, and hepatitis B following implementation of sexual risk behavior‐based screening in Canada

Transfusion, EarlyView.
Abstract Background In 2022, Canadian Blood Services implemented a gender‐neutral sexual behavior‐based screening (SBBS) approach to donor deferral, replacing time‐based criteria targeting gay, bisexual and other men who have sex with men (gbMSM) and female partners of gbMSM. We assessed the impact of this policy change on human immunodeficiency virus (
Chinchin Wang, Steven J. Drews, Mindy Goldman, Sheila F. O'Brien   +3 more
wiley   +1 more source

Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system. [PDF]

Microbiol Spectr
Zhao W, Singh K, Sozzi V, Cevaal P, Rossello FJ, Martelotto L, Zerbato JM, Rhodes A, Powell DR, Schröder J, Anderson J, Tumpach C, Fong D, Revill P, Crane M, Grimmond S, Roche M, Audsley J, Lewin SR.   +18 more
europepmc   +1 more source